Generalized root agenesis in permanent dentition of a young adolescent patient with rhabdomyosarcoma: a case report.
Chemotherapy
Craniofacial abnormalities
Head and neck cancer
Late effects
Rhabdomyosarcoma
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
17 Aug 2024
17 Aug 2024
Historique:
received:
30
04
2024
accepted:
06
08
2024
medline:
18
8
2024
pubmed:
18
8
2024
entrez:
17
8
2024
Statut:
epublish
Résumé
Parameningeal rhabdomyosarcoma (PM-RMS) is a rare and aggressive soft tissue malignancy that primarily occurs in the head and neck region. The standard treatment approach for RMS involves a multimodal therapy regimen, which includes surgery, chemotherapy, and radiotherapy. However, the routine use of radiotherapy and chemotherapy in young patients with RMS in the head and neck region can lead to adverse effects on dental development and thereby, pose a challenge in planning dental intervention. This case report outlines the dental and facial developmental consequences in a 13-year-old child, who received chemo-radiotherapeutic intervention at the age of 7 years for the management of PM-RMS. Following treatment, the child exhibited significant dental complications, including arrested root growth and restricted mouth opening. This case highlights the necessity for interdisciplinary collaboration between oncologists, dentists, and other healthcare professionals to mitigate the adverse effects on dental health and overall quality of life in patients undergoing chemo-radiotherapy for rhabdomyosarcoma.
Sections du résumé
BACKGROUND
BACKGROUND
Parameningeal rhabdomyosarcoma (PM-RMS) is a rare and aggressive soft tissue malignancy that primarily occurs in the head and neck region. The standard treatment approach for RMS involves a multimodal therapy regimen, which includes surgery, chemotherapy, and radiotherapy. However, the routine use of radiotherapy and chemotherapy in young patients with RMS in the head and neck region can lead to adverse effects on dental development and thereby, pose a challenge in planning dental intervention.
CASE PRESENTATION
METHODS
This case report outlines the dental and facial developmental consequences in a 13-year-old child, who received chemo-radiotherapeutic intervention at the age of 7 years for the management of PM-RMS. Following treatment, the child exhibited significant dental complications, including arrested root growth and restricted mouth opening.
CONCLUSIONS
CONCLUSIONS
This case highlights the necessity for interdisciplinary collaboration between oncologists, dentists, and other healthcare professionals to mitigate the adverse effects on dental health and overall quality of life in patients undergoing chemo-radiotherapy for rhabdomyosarcoma.
Identifiants
pubmed: 39154167
doi: 10.1186/s12903-024-04709-5
pii: 10.1186/s12903-024-04709-5
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
961Informations de copyright
© 2024. The Author(s).
Références
Bilhan H, Geckili O, Atalay B, Arat S. Oral rehabilitation following removal of a rhabdomyosarcoma and subsequent microstomia: a case report. J Oral Implantol. 2011;37(3):353–60.
doi: 10.1563/AAID-JOI-D-09-0116.1
pubmed: 21663453
Möller P, Perrier M. Dento-maxillofacial sequelae in a child treated for a rhabdomyosarcoma in the head and neck. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86(3):297–303.
doi: 10.1016/S1079-2104(98)90175-5
pubmed: 9768418
Kallen ME, Hornick JL. The 2020 WHO classification: what’s new in soft tissue tumor pathology? Am J Surg Pathol. 2021;45(1):e1–23.
doi: 10.1097/PAS.0000000000001552
pubmed: 32796172
Parameningeal rhabdomyosarcoma in. Pediatric age: results of a pooled analysis from north American and European cooperative groups. Ann Oncol. 2014;25(3):756.
doi: 10.1093/annonc/mdu001
Hettmer S, Li Z, Billin AN, Barr FG, Cornelison DD, Ehrlich AR, et al. Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb Perspect Med. 2014;4(11):a025650.
doi: 10.1101/cshperspect.a025650
pubmed: 25368019
pmcid: 4208704
Shern JF, Yohe ME, Khan J. Pediatric rhabdomyosarcoma. Crit Rev Oncog. 2015;20(3–4):227–43.
doi: 10.1615/CritRevOncog.2015013800
pubmed: 26349418
pmcid: 5486973
Mattos VD, Ferman S, Magalhães DMA, Antunes HS, Lourenço SQC. Dental and craniofacial alterations in long-term survivors of childhood head and neck rhabdomyosarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(4):272–81.
doi: 10.1016/j.oooo.2018.12.012
pubmed: 30685390
Gebre-Medhin M, Haghanegi M, Robért L, Kjellén E, Nilsson P. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncol. 2016;55(11):1313–7.
doi: 10.1080/0284186X.2016.1221129
pubmed: 27595312
van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CR, et al. Dysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiother Oncol. 2013;106(3):364–9.
doi: 10.1016/j.radonc.2013.03.005
pubmed: 23540551
Grundy R, Anderson J, Gaze M, Gerrard M, Glaser A, Gordon A, et al. Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children. Cancer. 2001;91(3):606–12.
doi: 10.1002/1097-0142(20010201)91:3<606::AID-CNCR1041>3.0.CO;2-M
pubmed: 11169945
Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19(12):3091–102.
doi: 10.1200/JCO.2001.19.12.3091
pubmed: 11408506
van der Pas-van Voskuilen IG, Veerkamp JS, Raber-Durlacher JE, Bresters D, van Wijk AJ, Barasch A, et al. Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer. 2009;17(9):1169–75.
doi: 10.1007/s00520-008-0567-1
pubmed: 19139926
Gawade PL, Hudson MM, Kaste SC, Neglia JP, Constine LS, Robison LL, et al. A systematic review of dental late effects in survivors of childhood cancer. Pediatr Blood Cancer. 2014;61(3):407–16.
doi: 10.1002/pbc.24842
pubmed: 24424790
Dholam KP, Gurav SV. Dental implants in irradiated jaws: a literature review. J Cancer Res Ther. 2012;8(Suppl 1):S85–93.
doi: 10.4103/0973-1482.92220
pubmed: 22322737
Goho C. Chemoradiation therapy: effect on dental development. Pediatr Dent. 1993;15(1):6–12.
pubmed: 8233995
Jaffe N, Toth BB, Hoar RE, Ried HL, Sullivan MP, McNeese MD. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics. 1984;73(6):816–23.
doi: 10.1542/peds.73.6.816
pubmed: 6728583
Carpenter JS. Dental care for children who have received head and neck therapeutic radiation. J Pedod. 1978;3(1):36–51.
pubmed: 397337
Diepstraten FA, Wiersma J, Schoot RA, Knops RRG, Zuur CL, Meijer AJM et al. Patterns of hearing loss in irradiated survivors of head and neck rhabdomyosarcoma. Cancers (Basel). 2022;14(23).
Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev. 2003;29(5):417–30.
doi: 10.1016/S0305-7372(03)00066-5
pubmed: 12972360
Meijer AJ, Li KH, Brooks B, Clemens E, Ross CJ, Rassekh SR, et al. The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Cancer. 2022;128(1):169–79.
doi: 10.1002/cncr.33848
pubmed: 34490624
Zhou L, Chen J, Tao CJ, Chen M, Yu ZH, Chen YY. Research progress of radiation-induced hypothyroidism in head and neck cancer. J Cancer. 2021;12(2):451–9.
doi: 10.7150/jca.48587
pubmed: 33391441
pmcid: 7738994
Lee V, Chan SY, Choi CW, Kwong D, Lam KO, Tong CC, et al. Dosimetric predictors of hypothyroidism after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma. Clin Oncol (R Coll Radiol). 2016;28(8):e52–60.
doi: 10.1016/j.clon.2016.05.004
pubmed: 27235379
Mishra S. Orthodontic therapy for paediatric cancer survivors: a review. J Clin Diagn Res. 2017;11(3):Ze01–4.
pubmed: 28658925
pmcid: 5483827
Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111(1):49–54.
doi: 10.14219/jada.archive.1985.0074
pubmed: 3897335
Devi S, Singh N. Dental care during and after radiotherapy in head and neck cancer. Natl J Maxillofac Surg. 2014;5(2):117–25.
doi: 10.4103/0975-5950.154812
pubmed: 25937720
pmcid: 4405951